Retraction: Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway (Molecular Medicine Reports (2013) 8 (361-366) DOI: 10.3892/mmr.2013.1507);Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 361-366

  Liu, Aiguo ^a,b   Gao, Xuan ^b   Zhang, Qingbin ^b   Cui, Lianqun ^a  

^a SHANDONG UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac dysfunction; Cardiac remodeling; Cathepsin B; Myocardial infarction; NLRP3

Indexed keywords

CA 074ME; CATHEPSIN B; CATHEPSIN B INHIBITOR; CRYOPYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IMMUNOFLUORESCENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORPHOMETRICS; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION;

RATTUS;

EID: 84879993001     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.7551     Document Type: Erratum

References (33)

1. Weber C and Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422, 2011.
2. Yousef Z, Redwood S and Marber M: Postinfarction left ventricular remodelling: where are the theories and trials leading us? Heart 83: 76-80, 2000.
3. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A and Frangogiannis NG: Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173: 57-67, 2008.
4. Bracey NA, Beck PL, Muruve DA, Hirota SA, Guo J, Jabagi H, Wright JR Jr, Macdonald JA, Lees-Miller JP, Roach D, et al: The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through IL-1β. Exp Physiol 98: 462-472, 2013.
5. Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF and Abbate A: The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 108: 19725-19730, 2011.
6. Niemi K, Teirilä L, Lappalainen J, Rajamäki K, Baumann MH, Öörni K, Wolff H, Kovanen PT, Matikainen S and Eklund KK: Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186: 6119-6128, 2011.
7. Boyle AJ, Kelly DJ, Zhang Y, Cox AJ, Gow RM, Way K, Itescu S, Krum H and Gilbert RE: Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol 39: 213-221,2005.
8. Van Acker GJ, Saluja AK, Bhagat L, Singh VP, Song AM and Steer ML: Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity. Am J Physiol Gastrointest Liver Physiol 283: G794-G800, 2002.
9. Matarrese P, Ascione B, Ciarlo L, Vona R, Leonetti C, Scarsella M, Mileo AM, Catricalà C, Paggi MG and Malorni W: Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study. Mol Cancer 9: 207, 2010.
10. Cavallo-Medved D, Dosescu J, Linebaugh BE, Sameni M, Rudy D and Sloane BF: Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia 5: 507-519, 2003.
11. Takaya T, Wada H, Morimoto T, Sunagawa Y, Kawamura T, Takanabe-Mori R, Shimatsu A, Fujita Y, Sato Y, Fujita M, et al: Left ventricular expression of lectin-like oxidized low-density lipoprotein receptor-1 in failing rat hearts. Circ J 74: 723-729, 2010.
12. Saito T, Rodger IW, Hu F, Robinson R, Huynh T and Giaid A: Some histological methods: Inhibition of COX pathway in experimental myocardial infarction. J Mol Cell Cardiol 37: 71-77, 2004.
13. Masson P: Trichrome stainings and their preliminary technique. J Tech Methods 2: 75-90, 1929.
14. Lal A, Veinot JP and Leenen FH: Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 64: 437-447, 2004.
15. Lehr HA, Mankoff DA, Corwin D, Santeusanio G and Gown AM: Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45: 1559-1565, 1997.
16. Lehr HA, Van der Loos CM, Teeling P and Gown AM: Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47: 119-126, 1999.
17. Duncan DJ, Yang Z, Hopkins PM, Steele DS and Harrison SM: TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 47: 378-386, 2010.
18. Bujak M and Frangogiannis NG: The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz) 57: 165-176, 2009.
19. Abbate A, Salloum FN, Vecile E, Das A, Hoke NN, Straino S, Biondi-Zoccai GG, Houser JE, Qureshi IZ, Ownby ED,et al: Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117: 2670-2683, 2008.
20. Van Tassell BW, Arena RA, Toldo S, Mezzaroma E, Azam T, Seropian IM, Shah K, Canada J, Voelkel NF, Dinarello CA and Abbate A: Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS One 7: e33438, 2012.
21. Abbate A, Kontos MC, Grizzard JD, Biondi-Zoccai GG, Van Tassell BW, Robati R, Roach LM, Arena RA, Roberts CS, Varma A, et al: Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction [Virginia Commonwealth University Anakinra Remodeling Trial (VCU-ART) Pilot study]. Am J Cardiol 105: 1371-1377, 2010.
22. Hoegen T, Tremel N, Klein M, Angele B, Wagner H, Kirschning C, Pfister HW, Fontana A, Hammerschmidt S and Koedel U: The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 187: 5440-5451, 2011.
23. Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, et al: NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 17: 1359-1372, 2011.
24. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA and Kubes P: Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366, 2010.
25. Cheng XW, Obata K, Kuzuya M, Izawa H, Nakamura K, Asai E, Nagasaka T, Saka M, Kimata T, Noda A, et al: Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension 48: 979-987, 2006.
26. Ge J, Zhao G, Chen R, Li S, Wang S, Zhang X, Zhuang Y, Du J, Yu X, Li G and Yang Y: Enhanced myocardial cathepsin B expression in patients with dilated cardiomyopathy. Eur J Heart Fail 8: 284-289, 2006.
27. Kumaran KS and Prince PS. Preventive effect of caffeic acid on lysosomal dysfunction in isoproterenol-induced myocardial infarcted rats. J Biochem Mol Toxicol 24: 115-122, 2010.
28. Jugdutt BI: Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108: 1395-1403, 2003.
29. Borg TK, Ranson WF, Moslehy FA and Caulfield JB: Structural basis of ventricular stiffness. Lab Invest 44: 49-54, 1981.
30. Strain JE, Grose RM, Factor SM and Fisher JD: Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease. Circulation 68: 1171-1181, 1983.
31. Artlett CM: The role of the NLRP3 inflammasome in fibrosis. Open Rheumatol J 6: 80-86, 2012.
32. Xu JF, Washko GR, Nakahira K, Hatabu H, Patel AS, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross C, et al: Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med 185: 547-556, 2012.
33. Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, Mahmood S, Jhandier MN, Shi Y, Flavell RA and Mehal WZ: Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 296: G1248-G1257, 2009.